Page last updated: 2024-10-22

amobarbital and Hospital-Acquired Condition

amobarbital has been researched along with Hospital-Acquired Condition in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research Excerpts

ExcerptRelevanceReference
"In this investigation, we compared iLTS scar-derived fibroblasts in patients with and without T2DM."1.62Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus. ( Davis, R; Ding, D; Hillel, AT; Lina, I; Motz, KM; Tsai, HW, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lina, I1
Tsai, HW1
Ding, D1
Davis, R1
Motz, KM1
Hillel, AT1

Other Studies

1 other study available for amobarbital and Hospital-Acquired Condition

ArticleYear
Characterization of Fibroblasts in Iatrogenic Laryngotracheal Stenosis and Type II Diabetes Mellitus.
    The Laryngoscope, 2021, Volume: 131, Issue:7

    Topics: Adult; Aged; Amobarbital; Biopsy; Case-Control Studies; Cell Proliferation; Cells, Cultured; Cicatri

2021